by EmpathiCSubstanceS | Jan 13, 2022 | Chronic Pain, Depression, Iboga, Kambo, LSD, MDMA Sassafras Molly, Pain, Parkinson's Disease
Perhaps one of the most important psychedelic science articles published in 2021 came when psychopharmacologist Suresh Muthukumaraswamy and colleagues Anna Forsythe and Thomas Lumley called out the big elephant in the room of psychedelic clinical trials. The...
by EmpathiCSubstanceS | Jan 13, 2022 | Depression, DMT, Iboga, Kambo, NN-Dimethyltryptamine, Pain, Parkinson's Disease
Cannabis is a remarkably understudied plant containing hundreds of novel molecules, many of which are yet to be scientifically cataloged. This new study set out to investigate what chemicals are responsible for the plant’s characteristic skunk-like smell. The...
by EmpathiCSubstanceS | Jan 13, 2022 | Iboga, MDMA Sassafras Molly, Neuropathy, OCD, Parkinson's Disease, Psilocybin Magic Mushroom, San Pedro Mescaline
The latest research into psilocybin therapy as a treatment for tobacco addiction has yielded promising results. Johns Hopkins Medicine was awarded a US$4-million grant by the National Institutes of Health (NIH) to further clinical research investigating...
by EmpathiCSubstanceS | Jan 13, 2022 | Cannabis Marijuana, Iboga, Kambo, MDMA Sassafras Molly, Microdosing, OCD
One of the most iconic, possibly apocryphal, drug stories of the 20th century is the tale of Pittsburgh Pirates pitcher Dock Ellis throwing a no-hitter while tripping on LSD in 1970. Ellis recounted his story in great detail to NPR shortly before his death, and the...
by EmpathiCSubstanceS | Jan 13, 2022 | Iboga, LSD, MDMA Sassafras Molly, Microdosing, Neuropathy, NN-Dimethyltryptamine, OCD, Psilocybin Magic Mushroom
With scientists now beginning to investigate the popular phenomenon of microdosing there are only anecdotes and reports from citizen scientists offering insights into the possible performance-enhancing effect of this behavior. The few published studies on microdosing...
